Thermo Fisher Scientific Inc. (TMO) |
| 526.02 -0.58 (-0.11%) 04-20 16:00 |
| Open: | 522.83 |
| High: | 528.82 |
| Low: | 521.14 |
| Volume: | 1,437,407 |
| Market Cap: | 195,480(M) |
| PE Ratio: | 29.63 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 622.38 |
| Resistance 1: | 532.86 |
| Pivot price: | 505.14 |
| Support 1: | 486.81 |
| Support 2: | 458.34 |
| 52w High: | 643.99 |
| 52w Low: | 385.46 |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
| EPS | 17.750 |
| Book Value | 141.960 |
| PEG Ratio | 1.95 |
| Gross Profit | 49.244 |
| Profit Margin (%) | 15.05 |
| Operating Margin (%) | 21.17 |
| Return on Assets (ttm) | 5.0 |
| Return on Equity (ttm) | 13.0 |
Mon, 20 Apr 2026
Thermo Fisher: Great Business Still Trading At A Risky Price Before Earnings (NYSE:TMO) - Seeking Alpha
Mon, 20 Apr 2026
Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today - Benzinga
Mon, 20 Apr 2026
Unlocking Q1 Potential of Thermo Fisher (TMO): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Sun, 19 Apr 2026
Is Thermo Fisher Scientific (TMO) Fairly Priced After Recent Share Price Rebound? - simplywall.st
Sat, 18 Apr 2026
Ninety One North America Inc. Makes New Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Sat, 18 Apr 2026
Thermo Fisher Scientific Inc. $TMO Stock Holdings Lifted by Ninety One SA Pty Ltd - MarketBeat
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |